Ultresa is approved for use in children age 12 months and older; some other pancrelipase products are approved for use in infants, but Ultresa is not. Ultresa comes only in capsule form, so a little creativity and patience is necessary in order to give this medication to young children (see Ultresa Dosage for more information).
On occasion, your healthcare provider may recommend this medicine for something other than the use discussed in this article. This is called an "off-label" use. Using Ultresa for infants would be considered an off-label use. Otherwise, there are no universally accepted off-label uses for Ultresa at this time.